The phase III ESCORT-NEO trial evaluated camrelizumab in combination with chemotherapy versus chemotherapy alone in the ...

Amgen (Nasdaq: AMGN) has completed construction of a $550 million drug manufacturing facility in the Wake County town.

This December, Amgen received a second state incentive to expand its Holly Springs operations by adding another drug ...

Amgen Inc . (NASDAQ:AMGN), a leading biopharmaceutical company with a market capitalization of $149 billion, is navigating a ...

Amgen executives and employees, local and state elected dignitaries, and an assortment of other local economic development ...

In a report released today, Gregory Renza from RBC Capital maintained a Buy rating on Amgen (AMGN – Research Report), with a price target of ...

With a ribbon cutting at one facility and a groundbreaking for another Friday, Amgen takes another concrete step towards a ...

Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its proprietary technology to its Tumor ...

The company says they will create hundreds of new jobs between 2028 and 2032, and the average pay will be more than $91,000 a year.

In our annual review of developments in Canadian patent law, we considered over 60 court decisions reported last year. In ...

As the next round of Medicare drug pricing negotiations get underway, experts predict President Trump may seek to weaken the program.

A discussion of the essential role that primary care physicians play in the management of patients’ overall and ...